In colorectal cancer cells (CRCs), biguanide exhibited its inhibitory effect on CRC growth by down-regulating the PI3K/AKT pathway and repressing the expression of inhibin BetaA (INHBA), an oncogene member of the TGF-beta family [86]. This evidence concerns the gene AKT1 and colorectal carcinoma.